Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: A randomized controlled trial

Iranian Journal of Kidney Diseases

Volumn 8, Issue 5, 2014, Pages 401-407

  Biniaz, Vajihe ^a   Tayebi, Ali ^a   Ebadi, Abbas ^a   Shermeh, Mahdi Sadeghi ^a   Einollahi, Behzad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemodialysis; Serum uric acid; Vitamin C

Indexed keywords

ASCORBIC ACID; CREATININE; URIC ACID; VITAMIN;

ADULT; AGED; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; HYPERURICEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ASCORBIC ACID; CREATININE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERURICEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME; URIC ACID; VITAMINS; YOUNG ADULT;

EID: 84906847553     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Castner D. Understanding the stages of chronic kidney disease. Nursing. 2010;40:24-31.
2. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.
3. Horigan AE. Fatigue in hemodialysis patients: a review of current knowledge. J Pain Symptom Manage. 2012;44:715-24.
4. Letchmi S, Das S, Halim H, et al. Fatigue experienced by patients receiving maintenance dialysis in hemodialysis units. Nurs Health Sci. 2011;13:60-4.
5. Cleary J, Drennan J. Quality of life of patients on haemodialysis for end-stage renal disease. J Adv Nurs. 2005;51:577-86.
6. Marinelli A, Orlandi L, Stivali G. C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on longterm hemodialysis. Clin Nephrol. 2011;76:425-34.
7. Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164:1546-51.
8. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension. 2006;47:195-202.
9. Madero M, Sarnak MJ, Wang X, et al. Uric acid and longterm outcomes in CKD. Am J Kidney Dis. 2009;53:796-803.
10. Chen SC, Chang JM, Yeh SM, Su HM, Chen HC. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease. Am J Hypertens. 2013;26:243-9.
11. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY. Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant. 2004;19:457-62.
12. Suliman ME, Johnson RJ, Garcia-Lopez E, et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis. 2006;48:761-71.
13. Lee SM, Lee AL, Winters TJ, et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol. 2009;29:79-85.
14. Latif W, Karaboyas A, Tong L, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6:2470-7.
15. Park JT, Kim DK, Chang TI, et al. Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant. 2009;24:3520-5.
16. Numakura K, Satoh S, Tsuchiya N, et al. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival. Transplantation. 2012;94:145-51.
17. Feng S, Jiang L, Shi Y, et al. Uric acid levels and all-cause mortality in peritoneal dialysis patients. Kidney Blood Press Res. 2013;37:181-9.
18. D'Marco L, Garcia I, Vega C. [Uric acid, atherosclerosis and vascular calcifications in chronic kidney disease]. Invest Clin. 2012;53:52-9.
19. Juraschek SP, Miller ER, III, Gelber AC. Effect of oral vitamin C supplementation on serum uric acid: a metaanalysis of randomized controlled trials. Arthritis Care Res (Hoboken). 2011;63:1295-306.
20. National Institute of Health [homepage on the internet]. Vitamin C factsheet for consumers [updated June 24, 2011]. Available from: http://ods.od.nih.gov/factsheets/ VitaminC-QuickFacts/
21. Jacob RA, Sotoudeh G. Vitamin C function and status in chronic disease. Nutr Clin Care. 2002;5:66-74.
22. Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr. 2007;137:2171-84.
23. Singer RF. Vitamin C supplementation in kidney failure: effect on uraemic symptoms. Nephrol Dial Transplant. 2011;26:614-20.
24. Coveney N, Polkinghorne KR, Linehan L, Corradini A, Kerr PG. Water-soluble vitamin levels in extended hours hemodialysis. Hemodial Int. 2010.
25. Zhang K, Dong J, Cheng X, et al. Association between vitamin C deficiency and dialysis modalities. Nephrology (Carlton). 2012;17:452-7.
26. Zhang K, Liu L, Cheng X, Dong J, Geng Q, Zuo L. Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein. BMC Nephrol. 2011;12:18.
27. Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15:26-34.
28. Willcox BJ, Curb JD, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol. 2008;101:75D-86D.
29. Deicher R, Horl WH. Vitamin C in chronic kidney diseaseand hemodialysis patients. Kidney Blood Press Res. 2003;26:100-6.
30. Huang HY, Appel LJ, Choi MJ, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum. 2005;52:1843-7.
31. Naziroglu M, Simsek M. Effects of hormone replacement therapy with vitamin C and E supplementation on plasma thyroid hormone levels in postmenopausal women with Type 2 diabetes. Biomed Pharmacother. 2009;63:717-22.
32. Shen L, Ji HF. Potential of vitamin C in the prevention and treatment of gout. Nat Rev Rheumatol. 2011;7:368.
33. Daugirdas JT, Leypoldt JK, Akonur A, Greene T, Depner TA. Improved equation for estimating single-pool Kt/V at higher dialysis frequencies. Nephrol Dial Transplant. 2013;28:2156-60.
34. Kurella M, Chertow G. Dialysis session length ("t") as a determinant of the adequacy of dialysis. Semin Nephrol. 2005;25:90-5.
35. Makar SH, Sawires HK, Farid TM, Ali WM, Schaalan M. Effect of high-flux versus low-flux dialysis membranes on parathyroid hormone. Iran J Kidney Dis. 2010;4:327-32.
36. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, et al. Predilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant. 2005;20:1155-63.
37. Heinz J, Domrose U, Westphal S, Luley C, Neumann KH, Dierkes J. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes. Nephrology (Carlton). 2008;13:384-9.
38. Fehrman-Ekholm I, Lotsander A, Logan K, Dunge D, Odar-Cederlof I, Kallner A. Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltration. Scand J Urol Nephrol. 2008;42:74-80.
39. Clermont G, Lecour S, Lahet J, et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res. 2000;47:618-23.
40. Sanadgol H, Bayani M, Mohammadi M, Bayani B, Mashhadi MA. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism. Iran J Kidney Dis. 2011;5:410-5.
41. Baradari AG, Emami ZA, Espahbodi F, Shahmohammadi S. Evaluation of serum C-reactive protein level and its related factors in hemodialysis patients in Sari, Iran. Pak J Biol Sci. 2011;14:595-9.
42. Weissinger EM, Nguyen-Khoa T, Fumeron C, et al. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics. 2006;6:993-1000.
43. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272-80.
44. Dashti-Khavidaki S, Talasaz AH, Tabeefar H, et al. Plasma vitamin C concentrations in patients on routine hemodialysis and its relationship to patients' morbidity and mortality. Int J Vitam Nutr Res. 2011;81:197-203.
45. Durose CL, Holdsworth M, Watson V, Przygrodzka F. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. J Am Diet Assoc. 2004;104:35-41.
46. Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant. 2002;17:422-7.
47. Shahbazian H, Zand MA, Ehsanpour A, Khazaali M. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis. Iran J Kidney Dis. 2009;3:151-5.
48. Handelman GJ. Vitamin C deficiency in dialysis patients- -are we perceiving the tip of an iceberg? Nephrol Dial Transplant. 2007;22:328-31.
49. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant. 2008;23:2058-63.